{"@id":"https://bioecon.ru/technology/bioactive-folates-for-eye-disease-autism/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://bioecon.ru/technology/bioactive-folates-for-eye-disease-autism/","json":"https://bioecon.ru/api/v1/technology/bioactive-folates-for-eye-disease-autism/index.json"},"id":"bioactive-folates-for-eye-disease-autism","industries":["pharma","wellness-prevention","longevity","food-ingredients"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/wellness-prevention/","https://bioecon.ru/industries/longevity/","https://bioecon.ru/industries/food-ingredients/"],"suppliers":["https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/pacific-biochar/","https://bioecon.ru/companies/stryker/","https://bioecon.ru/companies/brain-biotech/","https://bioecon.ru/companies/berkem-groupe/","https://bioecon.ru/companies/en-bio-tech/","https://bioecon.ru/companies/shree-renuka-sugars/","https://bioecon.ru/companies/alcon/"]},"maturity":9,"name":"Фармацевтические биоактивные L-метилфолаты при нейроофтальмологических патологиях и РАС","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Диастереоселективный синтез и оптическая кристаллизация"},{"n":2,"title":"Стабилизация кристаллической соли кальция и глюкозамина"},{"n":3,"title":"Тестирование транспорта через гематоэнцефалический барьер"},{"n":4,"title":"Клинические испытания при церебральной фолатной недостаточности"}],"summary":"Применение стабильного (6S)-5-метилтетрагидрофолата, проникающего через гематоэнцефалический барьер в обход дефектов MTHFR.","url":"/technology/bioactive-folates-for-eye-disease-autism/","verified":"2026-11-22"}